NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list Upvotes: 1